Evidence map›Paper›PMID 34050031›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Life 2.0-A CRISPR path to a sustainable planet.

Dana Carroll, Barbara J Meyer

Abstract readConference Proceedings
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dana CarrollDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650; dana@biochem.utah.edu.ORCID 0000-0002-3241-3331
Barbara J MeyerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3204.ORCID 0000-0002-6530-4588

Funding

Analysis of Nematode Sex Determination and Dosage CompensationR35GM131845 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MEYER, BARBARA J · 2019 to 2023
$2.3M
NIGMS NIH HHS R35 GM131845
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsGene EditingOrganisms, Genetically ModifiedAnimalsClustered Regularly Interspaced Short Palindromic RepeatsHumansSustainable Development

Identifiers

PMID34050031
PMCPMC8179165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.